Patents & Licensing Opportunities

Ceria nanoparticles for use in the treatment of hepatocellular carcinoma

This invention relates the use of cerium oxide single crystal nanoparticles (CeO2NPs) in the treatment of Hepatocellular Carcinoma (HCC). This treatment increases the survival of treated animals and reduce the proliferation of cancer cells.

See the full patent.

Download brochure

Updated: 16 October 2017

Licensed Technology: No

Involved research Group: Inorganic Nanoparticles

ICN2 researchers involved: Víctor F. Puntes